Radiotherapy-Driven Nanoprobes Targeting for Visualizing Tumor Infiltration Dynamics and Inducing Ferroptosis in Myeloid-Derived Suppressor Cells
Journal of the American Chemical Society · 14.08.2024 · 146 (32) · 22455-22468
DOI: 10.1021/jacs.4c05650 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Chemical Society, online erschienen am 02.08.2024. Verfasst von Wen Zhu und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X), Collaborative Innovation C…. Hauptthemen laut MEDLINE: Ferroptosis, Myeloid-Derived Suppressor Cells. Die Arbeit wurde bisher 26-mal zitiert (Crossref) und nennt 32 Literaturangaben. Gefördert von: Soochow University, State Key Laboratory of Radiation Medicine and Protection, National Natural Science Foundation of China.
Abstract (Originalsprache)
Myeloid-derived suppressor cells (MDSCs) significantly hinder the immune response to tumor radiotherapy (RT) because of their massive accumulation in tumors after RT, resulting in immunosuppression and poor clinical prognosis. Herein, we developed an anti-PD-L1 antibody-conjugated iron oxide nanoprobe (Fe3O4-αPD-L1) to target and induce ferroptosis in MDSCs, thereby alleviating RT resistance. Overexpression of PD-L1 in MDSCs following RT enables noninvasive in vivo magnetic resonance and positron emission tomography imaging using 89Zr-labeled nanoprobes to track the movement of MDSCs and their infiltration into the tumor. After uptake by MDSCs that infiltrated the tumor, Fe3O4-αPD-L1 nanoprobes were mainly found within the lysosome and triggered the Fenton reaction, resulting in the generation of abundant reactive oxygen species. This process leads to ferroptosis of MDSCs, characterized by lipid peroxidation and mitochondrial dysfunction, and effectively reprograms the immunosuppressive environment within the tumor following RT. This study highlights a strategy for monitoring and regulating the fate of MDSCs to alleviate RT resistance and ultimately achieve improved treatment outcomes.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Radiation Medicine and Protection, School for Radiological and Interdisciplinary Sciences (RAD-X), Collaborative Innovation Center of Radiation Medicine of Jiangsu Higher Education Institutions,…
- Department of Cardiothoracic Surgery, Suzhou Municipal Hospital Institution, Suzhou 215000, PR China.
ORCID-Profile: Leshuai W Zhang, Yong Wang
Förderung
- Soochow University
- State Key Laboratory of Radiation Medicine and Protection
- National Natural Science Foundation of China
- Priority Academic Program Development of Jiangsu Higher Education Institutions
- Tang Scholar Program
Zitieren
APA
Zhu, W., Cheng, X., Xu, P., Gu, Y., Xu, H., Xu, J., Wang, Y., Zhang, L. W., & Wang, Y. (2024). Radiotherapy-Driven Nanoprobes Targeting for Visualizing Tumor Infiltration Dynamics and Inducing Ferroptosis in Myeloid-Derived Suppressor Cells. Journal of the American Chemical Society, 146(32), 22455-22468. https://doi.org/10.1021/jacs.4c05650
Vancouver
Zhu W, Cheng X, Xu P, Gu Y, Xu H, Xu J, et al. Radiotherapy-Driven Nanoprobes Targeting for Visualizing Tumor Infiltration Dynamics and Inducing Ferroptosis in Myeloid-Derived Suppressor Cells. Journal of the American Chemical Society. 2024;146(32):22455-22468. doi:10.1021/jacs.4c05650
BibTeX
@article{Zhu2024,
author = {Zhu, Wen and Cheng, Xiaju and Xu, Pei and Gu, Yuan and Xu, Hanye and Xu, Jingwei and Wang, Yangyun and Zhang, Leshuai W and Wang, Yong},
title = {Radiotherapy-Driven Nanoprobes Targeting for Visualizing Tumor Infiltration Dynamics and Inducing Ferroptosis in Myeloid-Derived Suppressor Cells},
journal = {Journal of the American Chemical Society},
year = {2024},
volume = {146},
number = {32},
pages = {22455--22468},
doi = {10.1021/jacs.4c05650}
}
EUVIMED